🔗 Share this article

A shadow market for unlicensed slimming drugs is propelled by social media fitness personalities and vendors on communication apps, according to recent findings.

Experimental Treatment Acquiring Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its supposed weight-reducing effects. Viewers are urged to contact these accounts privately for source information, while also obtaining promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a flourishing market exists on messaging services, where groups with thousands of participants share comparison images, injection guides and claims of next-day UK delivery. Vendors promote the substance there before directing buyers to other platforms for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, physicians and pharmacists have warned that the distribution of what is still an unlicensed medication in the UK is worrisome and could lead to users administering products of uncertain source.

Some professionals said the demand for the experimental drug could be linked to the rising price of licensed slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that must not be marketed or distributed for human use under the British medical regulations.

Some influencers attempt to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate medicines, marketing, and customer laws, risking penalties, legal action or imprisonment.

Service Reaction and Material Removal

According to the social media company, the service has removed violative material and banned associated keywords and search suggestions. The organization said it was committed to keeping the service secure and allocating resources in enhancing compliance measures.

Online Trading Operations

Research also discovered communities with up to nine thousand participants marketing the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of members, populated with images of weight loss, glowing testimonials and detailed guides for mixing or administering at residence.

Within minutes of entering one group, a seller posted WhatsApp details, where most transactions take place. The seller provided an guidebook and guaranteed shipping within two days. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one asked about body mass, health issues or previous experience.

Product Details and Costs

Within these groups, posts show dark colored parcels with Royal Mail stickers, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at home with sterile water, or pre-filled pens usually priced at 160 pounds for 20 milligrams. When asked how long a injector should last, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A representative for Telegram stated it regularly moderated dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering materials they cannot confirm. Even if the science behind retatrutide is valid, these online products may not include what they claim,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service linked the surge in interest to recent price rises for authorized slimming medications such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit injections are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she explained.

Her team has already seen individuals injured by personal administration from unverified sources. “We recognize the disappointment, but purchasing from Telegram or communication platforms is taking chances with your health,” said the doctor. “These substances could be contaminated or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company stated the substance was in third stage research studies and had not been reviewed or approved by any regulatory agency globally. “Therefore at this point no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company investigational substance not yet authorized … may expose users to possibly significant health risks”.